Related Experiment Video
Updated: Feb 5, 2026
Actin Co-Sedimentation Assay; for the Analysis of Protein Binding to F-Actin
Published on: March 28, 2008
[Regulator proteins of actin dynamics as possible targets of antineoplastic therapies]
1Institut für Pathologie und Molekularpathologie, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081, Ulm, Deutschland. konradsteinestel@bundeswehr.org.
Background:
The ability of tumor cells to leave the primary tumor is prerequisite for metastatic spread. In previous studies, we identified regulator proteins of actin reorganization with essential functions in both synaptogenesis and tumor cell migration.
Objective:
The aim of the studies summarized in this article is to identify signaling pathways associated with actin-related proteins that might represent potential molecular targets for antiinvasive and/or antineoplastic therapies.
Materials And Methods:
We used immunohistochemical analyses of protein expression as well as in vitro techniques (cell culture, fluorescence microscopy, RNAi-based knockdown of protein expression, protein biochemistry and in vivo animal experiment substitutes).
Results:
We show that phosphorylation of Abelson interactor 1 (Abi1) is essential for the adhesion and invasion of colorectal carcinoma cells and might be targeted by the tyrosine kinase inhibitor STI571/Glivec®. HnRNP K, a protein interaction partner of Abi1, is upregulated in malignant melanoma in response to ionizing radiation; this upregulation is impaired upon application of the MEK inhibitor PD98059, enhancing radiosensivity of melanoma. Edelfosin, an alkyl-lipid blocker of the Abi1 interaction partner SK3, inhibits invasion of urothelial carcinoma cells.
Conclusion:
The studies summarized in this overview confirm a central role for the investigated proteins in tumor cell invasion and resistance to antineoplastic therapies and identify possible molecular targets for novel therapeutic compounds.
Insights
Tumor cell invasion and metastasis are linked to specific protein signaling pathways. Targeting proteins like Abi1 and HnRNP K with inhibitors may offer new anti-cancer therapies against tumor spread and treatment resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Tumor cell metastasis requires the ability to leave the primary tumor.
- Actin reorganization proteins are crucial for both synaptogenesis and tumor cell migration.
Purpose of the Study:
- Identify signaling pathways involving actin-related proteins.
- Discover potential molecular targets for anti-invasive and anti-neoplastic therapies.
Main Methods:
- Immunohistochemical analysis of protein expression.
- In vitro techniques including cell culture and fluorescence microscopy.
- RNAi-based knockdown, protein biochemistry, and in vivo animal models.
Main Results:
- Phosphorylation of Abelson interactor 1 (Abi1) is critical for colorectal carcinoma cell adhesion and invasion, potentially targetable by STI571/Glivec®.
- Heterogeneous nuclear ribonucleoprotein K (HnRNP K) upregulation in melanoma post-radiation is reduced by MEK inhibitor PD98059, enhancing radiosensitivity.
- Edelfosin, targeting Abi1 partner SK3, inhibits urothelial carcinoma cell invasion.
Conclusions:
- Investigated proteins play a key role in tumor cell invasion and resistance to cancer treatments.
- Identified potential molecular targets for novel therapeutic compounds in cancer therapy.
Related Concept Videos
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:58Regulated Protein Degradation
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
02:04Covalently Linked Protein Regulators
01:31Regulation of the Unfolded Protein Response